MedPage Today, March 14, 2017. The Republican’s repeal and replace bill, American Health Care Act, cleared two congressional committees and the Congressional Budget Office released its scoring report, Speaker of the House Paul Ryan (R-Wisc) says passing the GOP plan is a make or break issue Congress. So it is time to ask the pundits: what will happen if this bill becomes law?
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Trump’s FDA Nominee Spurs Concerns About Drug Approvals, Off-Label Promotion
Bloomberg BNA, March 14, 2017. President Donald Trump’s pick to head the FDA is spurring concerns about drug approvals and off-label promotion.
Read More »Trump Picks Scott Gottlieb to Serve as FDA Commissioner
Bloomberg Politics, March 10, 2017. While Gottlieb has focused on easing regulations, he “understands the agency and has some respect for it,” Diana Zuckerman, NCHR president, said in an interview before the news that Gottlieb is the leading candidate.
Read More »Drug Companies Are Exploiting This Law to Keep Prices High
Attn, March 8, 2017. Pharmaceutical companies are exploiting a Food and Drug Administration (FDA) policy to undermine competitors and maintain monopolies on their products.
Read More »Amid Flurry of New Cancer Drugs, How Many Offer Real Benefits?
Kaiser Health News, February 9, 2017. For every cancer patient who wins the lottery, there are many others who get little to no benefit from the latest drugs.
Read More »